Psilocybin, Multiple Sclerosis (MS) and ME/CFS: What Does the Research Say?
Interest in Psilocybin is growing as researchers explore its potential effects on complex neurological conditions like Multiple Sclerosis (MS) and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. While no clinical trials have directly tested psilocybin in these conditions, early research in related areas; such as chronic pain, post-viral illness, and neuroinflammation; is beginning to highlight mechanisms that may be relevant. From its influence on brain connectivity to its potential role in modulating inflammation, psilocybin is emerging as a compound of scientific interest, though much more research is needed to understand its true impact.




